December 06, 2012
Medicis Pharmaceutical Corp. fired the latest salvos Wednesday in an ongoing effort to protect its patents for the oral acne drug Solodyn, launching twin lawsuits targeting generic drug manufacturers that are seeking to produce generic versions of the drug.